Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Alaunos Therapeutics (TCRT) Interest Coverage Ratio (2021 - 2023)

Alaunos Therapeutics (TCRT) has disclosed Interest Coverage Ratio for 3 consecutive years, with 7.26 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Interest Coverage Ratio rose 44.99% year-over-year to 7.26, compared with a TTM value of 23.94 through Mar 2024, down 129.23%, and an annual FY2023 reading of 17.84, down 62.6% over the prior year.
  • Interest Coverage Ratio was 7.26 for Q2 2023 at Alaunos Therapeutics, up from 10.75 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 7.26 in Q2 2023 and bottomed at 50.22 in Q3 2021.
  • Average Interest Coverage Ratio over 3 years is 16.0, with a median of 11.97 recorded in 2022.
  • The sharpest move saw Interest Coverage Ratio skyrocketed 79.43% in 2022, then increased 19.21% in 2023.
  • Year by year, Interest Coverage Ratio stood at 14.62 in 2021, then skyrocketed by 42.68% to 8.38 in 2022, then grew by 13.39% to 7.26 in 2023.
  • Business Quant data shows Interest Coverage Ratio for TCRT at 7.26 in Q2 2023, 10.75 in Q1 2023, and 8.38 in Q4 2022.